Comparing Three Dimension Laparoscopic Versus Open Surgery for Perihiliar Cholangiocarcinoma

Last updated: October 5, 2020
Sponsor: Tongji Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Biliary Tract Cancer

Abdominal Cancer

Liver Cancer

Treatment

N/A

Clinical Study ID

NCT03383796
TJDBPS02
  • Ages 18-75
  • All Genders

Study Summary

Cholangiocarcinoma (CCA) is the most common biliary tract malignancy and the second most common primary hepatic malignancy. The prognosis of CCA is dismal. Surgery is the only potentially curative treatment, but the majority of patients present with advanced stage disease, and recurrence after resection is common. It is classified into intrahepatic (iCCA), perihilar (pCCA), and distal (dCCA) subtypes. Among all, pCCA is the most common subtype.

This is a prospective, randomized, controlled multicenter trial with two treatment arms, three dimension laparoscopic approach versus open approach. The trial hypothesis is that three dimension laparoscopic surgery has advantages in postoperative recoveries and be equivalent in operation time, oncological results and long-term follow-up compared with open counterpart. The duration of the entire trial is two years including prearrangement, follow-up and analyses.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Histologically proven pCCA.

  2. Highly presumed perihlar bile duct malignancy with difficulties to obtain histologicalevidence.

  3. Preoperative staging work up performed by upper abdomen enhanced CT scan.

  4. The subject understands the nature of this trial and willing to comply.

  5. Ability to provide written informed consent.

  6. Patients treated with curative intent in accordance to international guidelines

Exclusion

Exclusion Criteria:

  1. Distant metastases: peritoneal carcinomatosis, liver metastases, distant lymph nodemetastases, involvement of other organs.

  2. Subjects undergoing any part for hepatectomy.

  3. Patients with high operative risk as defined by the American Society ofAnesthesiologists (ASA) score >4.

  4. Synchronous malignancy in other organs.

  5. Palliative surgery

Study Design

Total Participants: 30
Study Start date:
March 01, 2018
Estimated Completion Date:
March 01, 2022

Connect with a study center

  • Tongji Hospital

    Wuhan, Hubei 430000
    China

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.